AQR Capital Management
PSTX

AQR Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

AQR Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$102K Sell
2024
Q3 		$927K Buy
2024
Q2 		$151K Buy
2024
Q1 		$34.6K Sell
2023
Q4 		$79.4K Sell
2023
Q3 		$207K Sell
2023
Q2 		$262K Buy
2023
Q1 		$108K Buy